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Abstract
Introduction: As the South African province of KwaZulu-Natal addresses a growing multidrug-resistant tuberculosis (MDR-
TB) epidemic by shifting care and treatment from trained specialty centers to community hospitals, delivering and
monitoring MDR-TB therapy has presented new challenges. In particular, tracking and reporting adverse clinical events have
been difficult for mobile healthcare workers (HCWs), trained health professionals who travel daily to patient homes to
administer and monitor therapy. We designed and piloted a mobile phone application (Mobilize) for mobile HCWs that
electronically standardized the recording and tracking of MDR-TB patients on low-cost, functional phones.
Objective: We assess the acceptability and feasibility of using Mobilize to record and submit adverse events forms weekly
during the intensive phase of MDR-TB therapy and evaluate mobile HCW perceptions throughout the pilot period.
Methods: All five mobile HCWs at one site were trained and provided with phones. Utilizing a mixed-methods evaluation,
mobile HCWs’ usage patterns were tracked electronically for seven months and analyzed. Qualitative focus groups and
questionnaires were designed to understand the impact of mobile phone technology on the work environment.
Results: Mobile HCWs submitted nine of 33 (27%) expected adverse events forms, conflicting with qualitative results in
which mobile HCWs stated that Mobilize improved adverse events communication, helped their daily workflow, and could
be successfully expanded to other health interventions. When presented with the conflict between their expressed views
and actual practice, mobile HCWs cited forgetfulness and believed patients should take more responsibility for their own
care.
Discussion: This pilot experience demonstrated poor uptake by HCWs despite positive responses to using mHealth. Though
our results should be interpreted cautiously because of the small number of mobile HCWs and MDR-TB patients in this
study, we recommend carefully exploring the motivations of HCWs and technologic enhancements prior to scaling new
mHealth initiatives in resource poor settings.
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South Africa’s health system is challenged by a multidrug-
resistant tuberculosis (MDR-TB) incidence rate of 70 per 100,000
people amidst a TB-HIV co-infection proportion of 65%, one of
the highest in the world [1–3]. High-burdened provinces like
KwaZulu-Natal (KZN) began shifting care in 2007 from a
hospital-based MDR-TB referral system to community-based
treatment centers, because referral hospitals could not accommo-
date the overwhelming demand for inpatient therapy initiation.
Moreover, patients traveled days for follow-up appointments and
medication refills, making medication adherence and retention in
care difficult [4–6].
Decentralizing care has expanded MDR-TB treatment access to
rural parts of KZN; however, this model of MDR-TB care
continues to struggle within a resource-strained health system [7].
KZN’s TB control program often faces drug shortages and
insufficient funds for personnel like mobile healthcare workers
(HCWs) who spend hours traversing poorly paved roads and rocky
terrain to administer injectable agents daily and conduct in-home
clinical assessments [4,5,8]. Effective clinical management and
monitoring have both suffered amidst resource constraints and as a
result mobile HCWs receive inadequate training and field support
for clinical decision-making.
In particular, tracking and addressing adverse events –
medication side effects or clinical deterioration – has been
inadequate [7,9]. Mobile HCWs have been asked to describe
symptoms on traditional paper forms in the field and then submit
them–a process that rarely happens. Moreover, symptom descrip-
tions can be vague, captured as either occurring or not, and lack
the level of detail sufficient for physicians to make clinical
decisions. Even after physician recommendations are made, plans
often take weeks to implement because of the inefficient
communication process. Monitoring for adverse events is not only
critical for patient safety but may also improve medication
adherence [10–15].
From 2010 to 2011, we designed and systematically piloted an
mHealth (mobile technologies for health) intervention, called
Mobilize, as one potential solution for improving the acceptability
feasibility of clinical monitoring and management of adverse
events in patients receiving community-based MDR-TB treat-
ment. The application of mHealth in low and middle-income
countries has been recognized as a promising, creative, and
potentially cost-effective intervention for healthcare workers
addressing a number of diseases and creating a diverse array of
interventions with varying degrees of efficacy and reproducibility
[16–21]. Our mobile phone application, Mobilize, electronically
standardizes the recording and tracking of adverse events
experienced by MDR-TB patients and utilizes simple, low-cost,
functional phones. It also provides clinical decision aids for
triaging emergent cases requiring attention and facilitates real-time
HCW-physician communication through automatic data transfers
from phones in the field to the physicians’ desk, reducing the cost
barrier of phone calls and communication delays.
Mobilize was the first known introduction of mHealth in this
resource-limited area. We performed a pragmatic trial, evaluating
the feasibility and acceptability of the intervention in everyday
clinical practice and allowing for adaptation to local needs [22–
25], and present a mixed-methods assessment of piloting Mobilize
at one decentralized treatment center in rural KZN, the Greytown
Specialized Drug-Resistant TB Treatment Hospital (GTN).
Methods
Ethical Review
Institutional review boards at the University of Michigan
Medical School, Yale University School of Medicine, and the
University of KwaZulu-Natal Biomedical Research Ethics Com-
mittee approved this study.
Study Site
KZN has a population of over 10 million, consisting largely of
poor, uneducated individuals, whose 2011 life-expectancy at birth
was 57.1 years [26]. Our work takes place in the Umzinyathi
District of KZN, which hosts GTN, the first of four decentralized
treatment centers in KZN. Each center treats a similar number of
MDR-TB patients annually, have comparable demographics–
treating the poorest individuals in the province, structure their
community-based treatment models similarly, and have outcomes
similar to the traditional, centralized, tertiary-care hospital [5,27].
Given the pilot nature of our study, we focused our intervention to
an Umzinyathi’s sub-district already using GTN for MDR-TB
care coordination. Mobile HCWs are trained health professionals
employed by the KZN Department of Health who are a critical
part of decentralized care. They are trained to administer an
injectable TB therapy at home, triage symptoms in the field,
transfer patients urgently to an inpatient facility, and trace (i.e.
track down) MDR-TB patients who are either newly diagnosed or
are defaulting (e.g. missing appointments or not adhering to
medications).
Mobilize Study Overview
The mobile phone application, CommCare [21,28], developed by
Dimagi, Inc., was iteratively modified into Mobilize (Figure 1) for
use during the study period of April to October 2011. The
standard KZN DOH paper forms (Figure 2) served as the basic
structure for the initial phone application. After feedback sessions
with mobile HCWs and community clinicians, Mobilize was further
modified for improved functionality and incorporated newly
suggested components: (1) decision aids for triaging symptom
complaints; (2) KZN DOH adherence questions; and (3) a tool for
tracing newly diagnosed TB patients, both standard and drug-
resistant, or finding defaulters from TB treatment.
Once the application was finalized, two investigators (K.H.C.
and M.L.) conducted an on-site, two-day training session with all
five of the active mobile HCWs employed at GTN, including one-
on-one in-field training with investigators prior to the beginning of
the study period. One head nurse and one data manager was
trained to organize the day-to-day operations for Mobilize and
provided local oversight. Additionally, technical and logistical
support was continuously available and provided on an as needed
basis. These were further addressed during scheduled conference
calls every two weeks and regular email communication.
Throughout the course of the seven-month study period airtime,
text, data for Internet use, car-based cellular chargers, and feature
phones (NokiaH 2700 and 2730 models) were supplied free of
charge to the five HCWs. In South Africa, airtime, text, and data
plans are typically purchased separately and are pre-paid until the
monetary amount is completely utilized or the purchase expires at
the end of the month. Therefore, we coordinated pre-paid
purchases of airtime, text messaging, and data that totaled
$11 USD and allowed each phone to receive two additional
recharges, or top-ups, to meet estimated demands for the phone’s
various functions, totaling a maximum of $33 USD per phone per
month. A similar phone plan was allocated for the phones held by
the onsite managers. Data entered on the phone was automatically
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health professionals and could be printed at any time point for the
patient’s paper record.
In accordance with South Africa’s national drug-resistant TB
treatment guidelines, mobile HCWs were asked to enter adverse
events weekly for each patient during the intensive phase – when
patients receive a daily injectable aminoglycoside for approxi-
mately 6 months in a 24-month treatment course [14]. We limited
our intervention to patients in the intensive phase because adverse
events are more typically experienced during this period compared
Figure 1. Screen shot images of Mobilize on the mobile phones.
doi:10.1371/journal.pone.0064662.g001
Figure 2. Traditional paper adverse events forms.
doi:10.1371/journal.pone.0064662.g002
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forms continued to be available, but mobile HCWs were
encouraged to primarily use Mobilize and carry paper forms for
recording in the case of a technical malfunction. The physician
and nursing staff based on-site at GTN regularly reviewed and
addressed voice calls, text messages, and forms from the online
database. Patients continued to attend their monthly follow-up
appointments at the GTN clinic. Each mobile HCW received a
mobile phone and the GTN-based staff shared one.
Sampling & Recruitment
We qualitatively interviewed all five mobile HCWs. One
investigator (K.H.C.) explained the project and obtained written
consent from participants. All verbal and written information was
delivered in English, a language requirement for all DOH clinical
employees.
Analytical Methods
A mixed-methods analysis was chosen to evaluate this pragmatic
trial for the purpose of informing policymakers at the KZN DOH
[20,22,25,30,31].
Quantitative
Study outcomes. The primary feasibility outcome was the
proportion of weekly adverse events forms submitted versus
expected by mobile HCWs. The expected number of forms was
based on the weekly number of GTN patients in the intensive
phase of MDR-TB therapy who were already being actively
tracked and managed through the pre-existing decentralized
MDR-TB treatment program. Patients entered the expected form
pool if they were in the intensive phase of therapy at the start of
the study period or started the intensive phase during the study
period. Patient data was censored if they were not at home during
the intensive phase (e.g. admitted as an inpatient), died during the
study period, transitioned to the continuation phase, or moved
into another sub-district. A baseline expected form submission
percentage was calculated for patients undergoing the intensive
phase of therapy between April 2010 and April 2011. Individual
HCW submission patterns were not analyzed as mobile HCWs
rotated which patients they saw on a daily basis. Secondary results
included perceived comfort levels with using mobile phone
technology as a measure of acceptability, the quality of adverse
events monitoring, and the proportion of reportable adverse events
being captured. These were assessed in a questionnaire adminis-
tered before implementation of Mobilize with all the HCWs in the
study, and then repeated at four months and after study
completion. The questionnaire assessed comfort using mobile
phones for adverse events monitoring (Likert scale), the quality of
adverse events reporting (Likert scale) and the percentage of
adverse events being captured (visual analogue scale, VAS)
through Mobilize. Statistical comparisons were not made given
the small sample size of our study.
Technical Outcomes. Phone usage patterns were tracked
based on how often money was being replenished into each phone.
However, delineating whether the phone was used for personal
matters or patient care was not technically feasible and recording
phone numbers dialed or texted could be inaccurate as mobile
HCWs might dial or text a variety of community members to
contact or track a patient. We recorded any technical problems
experienced by the mobile phones or the Mobilize application. All
descriptive data was analyzed using STATA v11 (StataCorp,
College Station, TX).
Qualitative
Data Collection. Qualitative data was collected through two
in-depth focus group interviews, completed four months after the
study start date and within two months post-study. Interviews
consisted of open-ended questions designed to address the
following topics: (1) perceptions on using mobile-phone technology
for monitoring adverse events, adherence, and tracing, and (2)
impacts of the mobile-phone technology on the personal work
environment. All interviews were conducted by K.H.C. or M.L. in
private locations (where conversations could not be overheard),
audio-recorded with permission, and averaged an hour in length
per interview.
Data Preparation & Analysis
South African research staff members transcribed the interviews
from audio recordings in pairs and then compared their results for
quality. K.H.C. and M.L. addressed discrepancies. Qualitative
analysis was directed towards developing an explanation of the
perceived quality of adverse events monitoring and the evolving
experiences of using mHealth technology. K.H.C. and M.L.
reviewed all transcriptions for analysis, creating a codebook to
categorize responses into major themes and perform line-by-line
coding of transcripts.
Results
Participant Characteristics
One of five mobile HCWs was female; the median age was 32
(range 27–46) years for all HCWs. The HCWs were employed by
the DOH for a median of 6 years (range 0.5–18) and had a median
3 years (range 0.5–5) of experience with MDR-TB patients. Two
mobile HCWs were nurses; three completed secondary schooling
without additional training. Pre-study, their median comfort level
with mobile devices was 8 (range 3–10, [0=‘‘Not at all’’ to
10=‘‘The most comfortable I will ever feel’’]).
Quantitative Results
Study outcomes. Within the seven-month study period, four
total patients were undergoing the intensive phase of treatment.
Mobile HCWs electronically submitted nine of 33 (27%) total
expected weekly adverse events forms (Table 1). Thirty-three
expected forms is calculated based on two patients who were in the
intensive phase for four weeks during the study period, one for
seven weeks, and one for 18 weeks. In comparison, 14 of 299 (5%)
expected paper forms were submitted for 16 patients, who had
variable amounts of time in the intensive phase, during the year
prior to our intervention. No paper forms were submitted during
our study period and, to our knowledge, the reporting of an
adverse event was not hampered by the absence of a traditional
paper form being available. Likert scale surveys found that most
mobile HCWs consistently felt comfortable using mobile phones
for adverse events monitoring and agreed that the quality of the
adverse events reported was good to excellent; however, none of
the follow-up VAS surveys indicated that all adverse events were
being captured during the study period.
Technical outcomes. A proxy for usage patterns was
assessed using the proportion of available airtime, SMS, and data
bundles that were refilled during the study period –55%, 33% and
18%, respectively. Mobile HCWs were unable to log into the
Mobilize application twice because the login screen froze. This issue
was fixed twice, within one week, by deleting and re-uploading a
new version of the application. To our knowledge, there were no
reported problems with uploading the data because of poor
cellular coverage or slow upload speeds. One mobile phone
Underuse of an mHealth Tool for MDR-TB Treatment
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were stolen or missing at the end of the study.
Qualitative Results
Overview. Results from focus group interviews conflicted
with the low return rate of adverse events forms. Mobile HCWs’
comments fell under four separate themes: (1) Mobilize improved
communication; (2) Mobilize improved their workflow; (3) Mobilize
could be expanded to help with other work related tasks; and (4)
challenges occurred with using the phone and phone application.
Theme 1: Mobilize improved communication. Mobile
HCWs noted how communication was increased with patients and
GTN-based staff, keeping them all in touch while they were
driving on the roads. Though they have always had personal
phones for use, mobile HCWs were reluctant to use them for
patient care because of the cost.
‘‘It is a very useful to have [the Mobilize phones] because at times…you
need to get hold of a [GTN staff members] now. Eish! With the pay
that we are getting we can’t afford to phone the landline during the day
[with our own phones] and often we wait for off peak times to phone…
with [the Mobilize phones] you just phone anytime.’’
By being able to communicate, they were able to provide more
timely patient care. Compared with paper forms one HCW stated,
‘‘We are reporting immediately as soon as we’re done, that means
that the continuity of care with the patient is not being disrupted in
any way.’’ Voice calls and text messaging functions were highly
regarded as they enabled collaboration when trying to find a
patient and reduced travel time. ‘‘We don’t have to [go to GTN]
all the time to report everything, it was done [over the phone] and
it made it easier for [GTN] to contact us and us to contact them,’’
stated one mobile HCW.
Moreover, after spending most of their days on the road, the
phones help the mobile HCWs feel more incorporated into the
team.
‘‘With [this phone] we are able to work as a team, this is a team
phone…it has made communication between the team quite good and
also for the patients because if you don’t communicate as a team…they
are getting less care than they should.’’
This team perspective was enhanced because mobile HCWs felt
the information transmitted with the Mobilize phone application
was more clinically useful for the patients compared with the
traditional paper forms. ‘‘Who was going to read the [paper]
form? We know [GTN staff] have received [the phone submission]
when you meet the [patient] after a clinic appointment and they
tell you they had [a medical issue] and then you see that [the
phone] has been effective,’’ stated one mobile HCW.
Many also felt that using mobile phones was a safer way to store
and transmit patient information compared with traditional paper
forms. One individual remarked:
‘‘Rather than carrying a whole lot of papers, you just carried a phone, it
had all that we needed instead of those papers…we lose them and we
lost them under the car seats or on the floor and you find them
everywhere…[the phone] is always in your pocket.’’
Theme 2: Mobilize improved workflow. With regards to
the three main features of the Mobilize phone application – adverse
events reporting, monitoring, and tracing, the mobile HCWs had
a positive perception of the application’s usefulness. Overall, they
felt that increasing the frequency of adverse events monitoring was
beneficial - ‘‘You are able to report if the patient complains of
anything and…we are doing it weekly so it is better that way.’’
Mobile HCWs believed they were previously able to avoid
adverse events monitoring because of limited oversight with the
traditional paper forms. With the phones, one individual believed
they felt like they were being monitored and more inclined to
conduct adverse events monitoring more frequently. One person
stated ‘‘were unable to neglect this form when we are using [the
phone].’’
The tracing component of the application built into the Mobilize
application was often mentioned as a positive feature because it
became ‘‘logistically simpler’’ and turn around times were
improved from three to four days down to one day between
tracing request and finding a patient in the field.
Theme 3: Expanding the scope of mobilize. The mobile
HCWs had a number of suggestions about how Mobilize could
benefit other health programs in the GTN area. As an example,
they often questioned why the scope was limited to only MDR-TB
patients. Their personal tasks were not limited to MDR-TB
patients; therefore, they expanded the use of the voice and text
messaging functions to caring for other patient populations, like
drug-sensitive TB and HIV patients. Further to this point, one
mobile HCW stated, ‘‘I think the phones would be helpful if not
only looks at TB. It should also look at other diseases or
problems…like immunizations and ante-natal care.’’ Another
mobile HCW believed utilizing the phone application for all TB
patients might prevent the development of resistance:
‘‘I feel that one of the predisposing causes of the [MDR-TB] is
improper management, so giving us a platform to actually communicate
so that we are trying to prevent the patient from going into the MDR/
XDR stage…So, we use the phone [for normal TB patients]…The
purpose is to prevent the patient from progressing into the stage that is
quite difficult to treat…[the phone] is not treatment. It is
communication. It will make quite a big difference.’’
Theme 4: Challenges. The phone experienced technical
issues that were related to the program periodically freezing which
occurred at least once every two weeks. At times when users were
trying to access the Mobilize program, they were unable to upload
data needed for the day, resulting in patient care delays. As one
worker stated:
Table 1. Quantitative data.
Baseline 4 month 7 month
Proportion of forms submitted,
actual (%)
14/299
*
(5%)
– 9/33 (27%)
Comfort with mobile phones (range) 8 (3–10) 7 (5–10) 8 (7–9)
Quality of AEs captured (range) 3 (3–3) 3 (2–5) 4 (2–5)
Percent of AEs captured, subjective
(range)
100
(30–100)
60
(50–80)
55
(30–70)
Comfort was based on a 10-point Likert scale [0=‘‘Not at all’’ to 10=‘‘The most
comfortable I will ever feel’’]). Quality was based on a 5-point Likert scale
[0=‘‘Poor’’ to 5=‘‘Excellent’’]. The subjective percent of AEs captured was
based on a VAS scale ranging from 0% (none) to 100% (all).
*Based on data collected from April 2010 to April 2011, the year prior to the
study period.
doi:10.1371/journal.pone.0064662.t001
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are waiting to log, log, log…We are talking about three to five minutes
waiting for [the program to start], instead of chatting with someone.’’
As a result, one user suggested, ‘‘I would like [DOH] to hire a
technician or a required person who would be dealing with the
phones 24 hours, 24/7.’’ Otherwise, HCWs felt the basic functions
of the phone, like voice calls and texts, worked without problems.
Moreover, mobile HCWs felt limited when discussing the
money allocated for airtime, as voice calls during daytime working
hours tend to be the most expensive. As a result, some believed
they were ‘‘doing a rush job through that call because we got to
save it for other patients too.’’
Conflicting results. Despite the overall positive reception
towards implementing mHealth in their daily workflow and the
positive response to having the phones and Mobilize available, the
program was used very little for the primary aim of the project,
adverse events monitoring. When asked directly, mobile HCWs
apologized at each focus group for not having had used the
Mobilize application more often during the study period, often
stating they had forgotten.
Moreover, in attempts to explain why forms – paper or
electronic, were not being completed as rigorously, mobile HCWs
generally felt that clinical staff should impart more patient
responsibility when discussing adherence. As one HCW states:
‘‘One of the reasons for adherence counseling is for them to be able to
take informed decisions about their lives and not for us to always be
doing things for them because at the end of the day, TB treatment will
be over, we will be gone, but they still need to be good. We don’t need to
baby sit them all the time, they need to take responsibility.’’
Discussion
We developed a pilot mHealth intervention, Mobilize, to address
inadequate reporting of adverse events and improve follow up of
MDR-TB patients being treated in a community-based program
in rural KZN. A low cost (Table 2) phone application was created
using an iterative design process, successfully deployed, and
qualitative feedback from our end-users (i.e. mobile HCWs) was
positive. Mobile HCWs expressed enthusiasm for the product
because it facilitated a sense of team between themselves and
clinic-based staff, while also allowing them to communicate more
readily and frequently with patients and not incur any personal
financial costs. Moreover, the ability to trace non-adherent or
patients lost-to-follow-up was well received because they no longer
had to drive back to GTN for notifications and could receive the
requests remotely. Though we cannot account for temporal trends,
the submission rate of adverse events generally improved from
paper forms (5%) to or mHealth application (27%), but both
methods resulted in poor submission rates. If mHealth is to play a
more critical role in care delivery, understanding the needs and
interests of healthcare workers using mHealth tools will be
important for uptake so public health departments can evaluate
whether mHealth technology helps achieve program objectives.
Additionally, assessments of mHealth interventions require objec-
tive outcomes, not simply indications of acceptability.
One explanation offered by mobile HCWs for forgetting to
check adverse events was an underlying sense that patients should
have more responsibility in their care. Future interventions for
improving adverse event monitoring should focus on understand-
ing the root cause of why HCWs may not be using mHealth
expected - whether the limitation is a structural barrier, lack of
personal motivation, or multifactorial. Technologic innovations
and applications are prone to the limitations encountered when
trying to change worker behaviors or beliefs. Despite being a part
of their job description, our HCWs believed patients, not mobile
HCWs, should be held responsible for reporting their symptoms.
Though not within the scope of this project, a deeper
understanding of the relationship between HCWs and patients
within the cultural context of our setting might be beneficial before
health programs develop interventions designed to improve
clinical care. Furthermore, the response of ‘‘I have forgotten’’
towards questions of accountability should be interpreted with
caution. It is plausible there are other reasons for not reporting
which we did not explore, and ‘‘forgetting’’ maybe a proxy for
alternative explanations. For instance, mobile HCWs might have
been reluctant to tell investigators due to a social desirability bias
to garner our approval.
Exploring features of the phone or technology perceived to be of
greatest utility might have helped set more realistic expectations of
uptake. Mobilize was implemented with the intent of providing a
phone application focused on improving the ease and efficiency of
adverse events monitoring, but HCWs found more benefit in being
able to complete basic text and voice calls with co-workers and
patients. Holden et al explores the complexity of uptake within the
Technology Acceptance Model for information technology in
healthcare, the perceived usefulness of technology ultimately
depends on what the HCW deems important [32]. The ease of use
does not correlate with the perception of a technology’s usefulness,
though having HCWs confidently able to use technology is a pre-
disposing step towards usefulness. We focused on developing and
customizing the phone application towards improving adverse
events monitoring and helping HCWs gain confidence in using
mobile technology, but improving adverse events was not what
HCWs believed to be the most useful component of the mobile
phones provided. Based on usage patterns, HCWs used the phone
mostly for text and voice communication given those features were
monetarily replenished regularly throughout the intervention
period. Additionally, in the iterative design process, clinical
providers might have diluted the perceptions of mobile HCWs
because they have a different vantage point regarding the use and
function of the mobile phones. Stronger consideration of end-user
perspectives may improve the uptake of future mHealth applica-
tions.
Moreover, mobile HCWs believed mobile phone interventions
should expand the scope beyond disease specific programs. Their
daily tasks are not limited to only MDR-TB patients. Mobile
Table 2. Cost data.
Items Cost (USD)
Training sessions 163.48
Project supplies (computer, copying, printing, etc.) 1,565.15
Mobile phones devices
* 1,073.66
Phone usage by HCWs
** 632.26
Total $3,434.55
Does not include the costs of salaries of personnel, travel, or living expenses. All
programming was done voluntarily by one of the investigators (SL). Dimagi
provided the CommCare platform for free.
*Nine total phones were purchased, a number were backup phones for any
potential technical malfunctions. **Phone usage costs were comprised of
airtime ($425.72), SMS ($128.45), and data costs ($78.09).
doi:10.1371/journal.pone.0064662.t002
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missed primary care, have HIV, or require additional home visits.
At the time of our study, the KZN Department of Health
separated their public health programs based on disease. For
example, the administrative oversight of TB was separated from
the HIV programs; yet, our mobile HCWs were asked to be a part
of both. Therefore, when considering their everyday work
environment – driving across an expansive terrain, communicat-
ing with multiple administrators and other clinical staff, mobile
HCWs may have seen our efforts to improve adverse events as
another burdensome task by a disease specific administrator
[9,33]. Similarly, the consideration of everyday, real-world work
constraints should be extended to clinicians and support staff
involved in implementing our mHealth intervention, as their tasks
often expanded beyond MDR-TB to primary care program needs.
Future mHealth interventions should explore the total work
environment needs for the total healthcare workforce and consider
interventions that meet the complexity of their work demands.
Considering this framework it is not unexpected that text and
voice calls were the most useful mobile phone features from the
outset.
In line with previous studies, the conflict between high interest
and low usage of mHealth has been observed in other resource-
limited settings. Haberer et al [18] found high participation
interests for using mHealth to measure antiretroviral therapy
adherence in rural Uganda using interactive voice response and
short messaging service, but the completion of adherence queries
was less than 33%. The major perceived limitation in achieving
better completion rates was due to a technical misunderstanding of
how to use mHealth technology, although motivation may have
also played a role. In the Mobilize study, we provided in-depth
training for a well-educated user population prior to implemen-
tation and technical support throughout, but we had similarly low
user uptake.
Though we have learned a number of important lessons, our
results should be interpreted cautiously because of the small
number of mobile HCWs and the technical limitations of our pilot
study. We do not know, for example, how uptake might have
changed over time or the impact of having regular oversight from
local, more senior clinical staff. Conclusions from this study site
may not be generalizable to other areas because the demographics
of our mobile HCWs; for example a more predominantly female
HCW cohort might have had higher uptake [34]. We were unable
to track the technical barriers our mobile HCWs might have
experienced like electronic submission errors or screen freezes,
because we did not have the technical capacity to track such errors
electronically nor did we incorporate a manual recording system
in our study design. Detailed usage patterns, like whether the
phone was used more for personal matters versus work-related
tasks, could not be recorded because we lacked the technical
capacity to track them also. Closer, real-time monitoring and
evaluation of staff performance might improve uptake of mHealth
interventions and work performance.
In conclusion, mHealth interventions are a complex interplay
between the motivations of the end-user and the functional
applicability of the technology in everyday work environments.
We were able to successfully train and deploy a customized
mHealth program in a rural, resource-poor, sub-Saharan Africa
setting with high acceptability and buy-in from clinical coordina-
tors and health professionals but fell short of our goal to feasibly
improve the quantity of adverse events monitoring. Current efforts
are underway in rural KZN to strengthen the total public health
infrastructure. If mHealth is to assist, research should further
explore the motivations of HCWs within the context of their
workflow limitations and improved technology for closer, real-time
performance monitoring to create a scalable intervention that is
more likely to improve our awareness of adverse events that have
occurred and then ultimately turn our focus towards properly
managing these events.
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